Disruptive Mood Dysregulation Disorder Associated with Autism Spectrum Disorder: Literature Review and Case Illustrations
DOI:
https://doi.org/10.33700/jhrs.1.1.45Keywords:
Autism Spectrum Disorder, Disruptive Mood Dysregulation Disorder, Case Series, Pharmacological Treatment, ComorbiditiesAbstract
Introduction: Irritability has become increasingly prevalent over the past few decades and is often seen in both children with autism spectrum disorder (ASD), and disruptive mood dysregulation disorder (DMDD). Despite this overlap, there has been scant research on treatment for irritability experienced by individuals with co-occurring ASD and DMDD.
Objectives: This paper aims to explore the development of DMDD and to shed light on potential treatment regimens that address irritability through case illustrations of individuals who experience co-occurring ASD and DMDD.
Methods: Three patients seen through a specialty clinic were selected based on their co-occurring diagnoses of ASD & DMDD.
Conclusions: The case illustrations showed that ASD and DMDD often also occurred in the presence of other disorders. Antipsychotics and CBT have shown the most benefits, but mood stabilizers are becoming more prominent for certain combinations of ASD and DMDD. More research is needed on treatment for irritability across co-occurring disorders.
Metrics
Show data table
Show data table
Metrics by source
Downloads
References
American Psychiatric Association. (2013). Diag-nostic and statistical manual of mental disorders (5th ed.). DOI: https://doi.org/10.1176/appi.books.9780890425596
Benarous, X., Ferrafiat, V., Zammit, J., Consoli, A., Gérardin, P., Guilé, J., & Cohen, D. (2020). Ef-fec-tive use of atomoxetine to treat six inpatient youths with disruptive mood dysregulation dis-order with-out attention deficit disorder. CNS Spec-trums, 25(4), 455-457. DOI: https://doi.org/10.1017/S1092852919001020
Blader, J. C., & Carlson, G. A. (2007). Increased rates of bipolar disorder diagnoses among US child, adolescent, and adult inpatients, 1996–2004. Biological Psychiatry, 62(2), 107-114. DOI: https://doi.org/10.1016/j.biopsych.2006.11.006
Breaux, R., Baweja, R., Eadeh, H. M., Shroff, D. M., Cash, A. R., Swanson, C. S., Knehans, A., & Waxmonsky, J. G. (2022). Systematic review and meta-analysis: Pharmacological and non-pharmacological interventions for persistent non-episodic irritability. Journal of the Ameri-can Acad-emy of Child & Adolescent Psychia-try. DOI: https://doi.org/10.1016/j.jaac.2022.05.012
Brotman, M. A., Kassem, L., Reising, M. M., Guy-er, A. E., Dickstein, D. P., Rich, B. A., Towbin, K. E., Pine, D. S., McMahon, F. J., & Leibenluft, E. (2007). Parental diagnoses in youth with nar-row phenotype bipolar disorder or severe mood dysreg-ulation. American Journal of Psychiatry, 164(8), 1238-1241. DOI: https://doi.org/10.1176/appi.ajp.2007.06101619
Brotman, M. A., Schmajuk, M., Rich, B. A., Dick-stein, D. P., Guyer, A. E., Costello, E. J., Egger, H. L., Angold, A., Pine, D. S., & Leibenluft, E. (2006). Prevalence, clinical correlates, and lon-gitudinal course of severe mood dysregulation in chil-dren. Biological Psychiatry, 60(9), 991-997. DOI: https://doi.org/10.1016/j.biopsych.2006.08.042
Brotman, M. A., Rich, B. A., Guyer, A. E., Luns-ford, J. R., Horsey, S. E., Reising, M. M., Thom-as, L. A., Fromm, S. J., Towbin, K., Pine, D. S., & Leibenluft, E. (2010). Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder. American Journal of Psychia-try, 167(1), 61-69. DOI: https://doi.org/10.1176/appi.ajp.2009.09010043
Bruno, A., Celebre, L., Torre, G., Pandolfo, G., Mento, C., Cedro, C., Zoccali., R. A., & Musca-tello, M. R. A. (2019). Focus on disruptive mood dysreg-ulation disorder: A review of the litera-ture. Psychiatry Research, 279, 323-330. DOI: https://doi.org/10.1016/j.psychres.2019.05.043
Cohen, D., Raffin, M., Canitano, R., Bodeau, N., Bonnot, O., Périsse, D., Consoli, A., & Laurent, C. (2013). Risperidone or aripiprazole in chil-dren and adolescents with autism and/or intel-lectual disabil-ity: A Bayesian meta-analysis of efficacy and sec-ondary effects. Research in Au-tism Spectrum Dis-orders, 7(1), 167-175. DOI: https://doi.org/10.1016/j.rasd.2012.08.001
Connor, D. F., Boone, R. T., Steingard, R. J., Lopez, I. D., & Melloni Jr, R. H. (2003). Psychophar-ma-cology and aggression: II. A meta-analysis of non-stimulant medication effects on overt aggression-related behaviors in youth with SED. Journal of Emotional and Behavioral Disorders, 11(3), 157-168. DOI: https://doi.org/10.1177/10634266030110030301
Connor, D. F., Findling, R. L., Kollins, S. H., Sallee, F., López, F. A., Lyne, A., & Tremblay, G. (2010). Effects of guanfacine extended release on opposi-tional symptoms in children aged 6–12 years with attention-deficit hyperactivity disorder and opposi-tional symptoms. CNS Drugs, 24(9), 755-768. DOI: https://doi.org/10.2165/11537790-000000000-00000
Copeland, W. E., Shanahan, L., Egger, H., Angold, A., & Costello, E. J. (2014). Adult diagnostic and functional outcomes of DSM-5 disruptive mood dysregulation disorder. American Journal of Psy-chiatry, 171(6), 668-674. DOI: https://doi.org/10.1176/appi.ajp.2014.13091213
Copeland, W. E., Angold, A., Costello, E. J., & Eg-ger, H. (2013). Prevalence, comorbidity, and corre-lates of DSM-5 proposed disruptive mood dysregu-lation disorder. American Journal of Psychia-try, 170(2), 173-179. DOI: https://doi.org/10.1176/appi.ajp.2012.12010132
Deveney, C. M., Connolly, M. E., Haring, C. T., Bones, B. L., Reynolds, R. C., Kim, P., Pine, D. S., & Leibenluft, E. (2013). Neural mechanisms of frustration in chronically irritable children. American Journal of Psychiatry, 170(10), 1186-1194. DOI: https://doi.org/10.1176/appi.ajp.2013.12070917
Dickstein, D. P., Towbin, K. E., Van Der Veen, J. W., Rich, B. A., Brotman, M. A., Knopf, L., Onelio, L., Pine, D. S., & Leibenluft, E. (2009). Random-ized double-blind placebo-controlled trial of lithi-um in youths with severe mood dysregula-tion. Journal of Child and Adolescent Psychophar-macology, 19(1), 61-73. DOI: https://doi.org/10.1089/cap.2008.044
Dickstein, D. P., Barthelemy, C. M., Jenkins, G. A., DeYoung, L. L., Gilbert, A. C., Radoeva, P., Kim, K. L., & MacPherson, H. A. (2021). This is your brain on irritability: A clinician's guide to under-standing how we know what we know now, and what we need to know in the future, about irritabil-ity in children and adolescents. Child and Adoles-cent Psychiatric Clinics, 30(3), 649-666. DOI: https://doi.org/10.1016/j.chc.2021.04.013
Fallah, M. S., Shaikh, M. R., Neupane, B., Rusiecki, D., Bennett, T. A., & Beyene, J. (2019). Atypical antipsychotics for irritability in pediatric au-tism: a systematic review and network meta-analysis. Journal of Child and Adolescent Psy-cho-pharmacology, 29(3), 168-180. DOI: https://doi.org/10.1089/cap.2018.0115
Findling, R. L., Robb, A., McNamara, N. K., Pavuluri, M. N., Kafantaris, V., Scheffer, R., Fra-zier, J. A., Rynn, M., DelBello, M., Kowatch, R. A., Rowles, B. M., Lingler, J., Martz, K., Anand, R., Clemons, T. E., & Taylor-Zapata, P. (2015). Lithi-um in the acute treat-ment of bipolar I disorder: A double-blind, pla-cebo-controlled study. Pediatrics, 136(5), 885-894. DOI: https://doi.org/10.1542/peds.2015-0743
Findling, R. L., McNamara, N. K., Pavuluri, M., Frazier, J. A., Rynn, M., Scheffer, R., Kafantaris, V., Robb, A., Delbello, M., Kowatch, R. A., Rowles, B. M., Lingler, J., Zhao, J., Clemons, T., Martz, K., Anand, R., & Taylor-Zapata, P. (2019). Lithium for the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled dis-continuation study. Journal of the American Acad-emy of Child & Adolescent Psychiatry, 58(2), 287-296. DOI: https://doi.org/10.1016/j.jaac.2018.07.901
Fristad, M. A., Gavazzi, S. M., & Mackinaw-Koons, B. (2003). Family psychoeducation: An adjunctive intervention for children with bipolar disorder. Biological Psychiatry, 53(11), 1000-1008. DOI: https://doi.org/10.1016/S0006-3223(03)00186-0
Fristad, M. A., Goldberg‐Arnold, J. S., & Gavazzi, S. M. (2002). Multifamily psychoeducation groups (MFPG) for families of children with bipolar dis-order. Bipolar Disorders, 4(4), 254-262. DOI: https://doi.org/10.1034/j.1399-5618.2002.09073.x
Fung, L. K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., Coury, D., Whitaker, A., Veenstra-Vanderweele, J., & Hardan, A. Y. (2016). Pharmacologic treatment of severe irri-tability and problem behaviors in autism: A sys-tematic review and meta-analysis. Pediatrics, 137 (Supplement 2), S124-S135. DOI: https://doi.org/10.1542/peds.2015-2851K
Goldstein, T. R., Axelson, D. A., Birmaher, B., & Brent, D. A. (2007). Dialectical behavior thera-py for adolescents with bipolar disorder: A 1-year open trial. Journal of the American Acad-emy of Child & Adolescent Psychiatry, 46(7), 820-830. DOI: https://doi.org/10.1097/chi.0b013e31805c1613
Hazell, P. L., & Stuart, J. E. (2003). A randomized controlled trial of clonidine added to psychost-imu-lant medication for hyperactive and ag-gressive children. Journal of the American Academy of Child & Adolescent Psychiatry, 42(8), 886-894. DOI: https://doi.org/10.1097/01.CHI.0000046908.27264.00
Hendrickson, B., Girma, M., & Miller, L. (2020). Review of the clinical approach to the treatment of disruptive mood dysregulation disor-der. In-ternational Review of Psychiatry, 32(3), 202-211. DOI: https://doi.org/10.1080/09540261.2019.1688260
Hlastala, S. A., Kotler, J. S., McClellan, J. M., & McCauley, E. A. (2010). Interpersonal and so-cial rhythm therapy for adolescents with bipolar disor-der: treatment development and results from an open trial. Depression and Anxiety, 27(5), 457-464. DOI: https://doi.org/10.1002/da.20668
Jain, U. (2017). The use of guanfacine (Intuniv XR) in the treatment of disruptive mood dysregula-tion disorder – Clinical experience from telepsychia-try. European Psychiatry, 41(S1), S442-S442. doi:10.1016/j.eurpsy.2017.01.449 DOI: https://doi.org/10.1016/j.eurpsy.2017.01.449
Jaselskis, C. A., Cook, E. H., Fletcher, K. E., & Le-venthal, B. L. (1992). Clonidine treatment of hy-peractive and impulsive children with autistic dis-order. Journal of Clinical Psychopharmaco-lo-gy, 12(5), 322-327. DOI: https://doi.org/10.1097/00004714-199210000-00005
Kelly, C., Molcho, M., Doyle, P., & Gabhainn, S. N. (2010). Psychosomatic symptoms among schoolchildren. International Journal of Adoles-cent Medicine and Health, 22(2), 229-236. DOI: https://doi.org/10.1515/IJAMH.2010.22.2.229
Krieger, F. V., Pheula, G. F., Coelho, R., Zeni, T., Tramontina, S., Zeni, C. P., & Rohde, L. A. (2011). An open-label trial of risperidone in children and adolescents with severe mood dysregula-tion. Journal of Child and Adolescent Psychophar-macology, 21(3), 237-243. DOI: https://doi.org/10.1089/cap.2010.0123
Leibenluft, E. (2011). Severe mood dysregulation, irritability, and the diagnostic boundaries of bi-polar disorder in youths. American Journal of Psychia-try, 168(2), 129-142. DOI: https://doi.org/10.1176/appi.ajp.2010.10050766
Leibenluft, E., Charney, D. S., Towbin, K. E., Bhangoo, R. K., & Pine, D. S. (2003). Defining clinical phenotypes of juvenile mania. Ameri-can Journal of Psychiatry, 160(3), 430-437. DOI: https://doi.org/10.1176/appi.ajp.160.3.430
Leibenluft, E., Cohen, P., Gorrindo, T., Brook, J. S., & Pine, D. S. (2006). Chronic versus episodic ir-ri-tability in youth: A community-based, longi-tudinal study of clinical and diagnostic associa-tions. Journal of Child & Adolescent Psycho-phar-macology, 16(4), 456-466. DOI: https://doi.org/10.1089/cap.2006.16.456
Leibenluft, E., & Stoddard, J. (2013). The devel-opmental psychopathology of irritabil-ity. De-velopment and psychopathology, 25, 1473-1487. DOI: https://doi.org/10.1017/S0954579413000722
Lecavalier, L. (2006). Behavioral and emotional problems in young people with pervasive devel-opmental disorders: Relative prevalence, effects of subject characteristics, and empirical classifi-ca-tion. Journal of Autism and Developmental Disor-ders, 36, 1101–1114. doi:10.1007/s10803-006-0147-5 DOI: https://doi.org/10.1007/s10803-006-0147-5
Mattes, J. A. (1986). Psychopharmacology of tem-per outbursts: A review. The Journal of Nervous and Mental Disease, 174(8), 464-470. DOI: https://doi.org/10.1097/00005053-198608000-00004
Mayes, S. D., Waxmonsky, J., Calhoun, S. L., Ko-kotovich, C., Mathiowetz, C., & Baweja, R. (2015). Disruptive mood dysregulation disorder (DMDD) symptoms in children with autism, ADHD, and neurotypical development and im-pact of co-occurring ODD, depression, and anx-iety. Research in Autism Spectrum Disorders, 18, 64-72. DOI: https://doi.org/10.1016/j.rasd.2015.07.003
Mayes, S. D., Kokotovich, C., Mathiowetz, C., Baweja, R., Calhoun, S. L., & Waxmonsky, J. (2017). Disruptive mood dysregulation disorder symptoms by age in autism, ADHD, and gen-eral population samples. Journal of Mental Health Re-search in Intellectual Disabilities, 10(4), 345-359. DOI: https://doi.org/10.1080/19315864.2017.1338804
McClellan, J., Kowatch, R., & Findling, R. L. (2007). Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. Journal of the American Acad-emy of Child & Adolescent Psychiatry, 46(1), 107-125. DOI: https://doi.org/10.1097/01.chi.0000242240.69678.c4
Miklowitz, D. J., Simoneau, T. L., George, E. L., Richards, J. A., Kalbag, A., Sachs-Ericsson, N., & Suddath, R. (2000). Family-focused treat-ment of bipolar disorder: 1-year effects of a psychoeduca-tional program in conjunction with pharmacothera-py. Biological Psychiatry, 48(6), 582-592. DOI: https://doi.org/10.1016/S0006-3223(00)00931-8
Miklowitz, D. J., Axelson, D. A., Birmaher, B., George, E. L., Taylor, D. O., Schneck, C. D., Ber-esford, C. A., Dickinson, M. L., Craighead, E. W., & Brent, D. A. (2008). Family-focused treatment for adolescents with bipolar disorder: Results of a 2-year randomized trial. Archives of General Psy-chiatry, 65(9), 1053-1061. DOI: https://doi.org/10.1001/archpsyc.65.9.1053
Moreno, C., Laje, G., Blanco, C., Jiang, H., Schmidt, A. B., & Olfson, M. (2007). National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of Gen-eral Psy-chiatry, 64(9), 1032-1039. DOI: https://doi.org/10.1001/archpsyc.64.9.1032
Osterman, K., & Bjorkqvist, K. (2010). A cross-sectional study of onset, cessation, frequency, and duration of children’s temper tantrums in a non-clinical sample. Psychological Reports, 106, 448–454. doi:10.2466/pr0.106.2.448-454 DOI: https://doi.org/10.2466/pr0.106.2.448-454
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., Carson, W. H., & Findling, R. L. (2009). Aripiprazole in the treat-ment of irritability in children and adoles-cents with autistic disorder. Pediatrics, 124(6), 1533-1540. DOI: https://doi.org/10.1542/peds.2008-3782
Palumbo, D. R., Sallee, F. R., Pelham Jr, W. E., Bukstein, O. G., Daviss, W. B., McDermott, M. P., & CAT Study Team. (2008). Clonidine for atten-tion-deficit/hyperactivity disorder: I. Effi-cacy and tolerability outcomes. Journal of the American Academy of Child & Adolescent Psychiatry, 47(2), 180-188. DOI: https://doi.org/10.1097/chi.0b013e31815d9af7
Pappadopulos, E., Woolston, S., Chait, A., Perkins, M., Connor, D. F., & Jensen, P. S. (2006). Pharma-cotherapy of aggression in children and adoles-cents: Efficacy and effect size. Journal of the Cana-dian Academy of Child and Adoles-cent Psychiatry.
Patino, L. R., Bruns, K. M., Witt, N. M., McCune, N. R., & DelBello, M. P. (2015). Management of bipolar disorder in children and adoles-cents. Focus, 13(1), 25-36. DOI: https://doi.org/10.1176/appi.focus.130121
Pavuluri, M. N., Graczyk, P. A., Henry, D. B., Car-bray, J. A., Heidenreich, J., & Miklowitz, D. J. (2004). Child-and family-focused cognitive-behavioral therapy for pediatric bipolar disor-der: Development and preliminary results. Journal of the American Academy of Child & Adolescent Psychiatry, 43(5), 528-537. DOI: https://doi.org/10.1097/00004583-200405000-00006
Peterson, B. S., Zhang, H., Santa Lucia, R., King, R. A., & Lewis, M. (1996). Risk factors for pre-senting problems in child psychiatric emergen-cies. Journal of the American Academy of Child & Adolescent Psychiatry, 35(9), 1162-1173. DOI: https://doi.org/10.1097/00004583-199609000-00014
Pisano, S., Pozzi, M., Catone, G., Scrinzi, G., Clem-enti, E., Coppola, G., Milone, A., Bravaccio, C., Santosh, P., & Masi, G. (2019). Putative Mecha-nisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Re-view. Current Neuropharmacology, 17(4), 318–341. DOI: https://doi.org/10.2174/1570159X16666171219142120
Politte, L. C., & McDougle, C. J. (2014). Atypical antipsychotics in the treatment of children and ado-lescents with pervasive developmental disor-ders. Psychopharmacology, 231(6), 1023-1036. DOI: https://doi.org/10.1007/s00213-013-3068-y
Rich, B. A., Schmajuk, M., Perez-Edgar, K. E., Fox, N. A., Pine, D. S., & Leibenluft, E. (2007). Dif-fer-ent psychophysiological and behavioral re-sponses elicited by frustration in pediatric bipo-lar disorder and severe mood dysregulation. American Journal of Psychiatry, 164(2), 309-317. DOI: https://doi.org/10.1176/ajp.2007.164.2.309
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A., Co-hen, D. J., & Leckman, J. F. (2001). A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention defi-cit hy-peractivity disorder. American Journal of Psychia-try, 158(7), 1067-1074. DOI: https://doi.org/10.1176/appi.ajp.158.7.1067
Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., & Dunbar, F. (2004). Risperidone in the treatment of disruptive behavioral symp-toms in children with autistic and other perva-sive develop-mental disorders. Pediatrics, 114(5), e634-e641. DOI: https://doi.org/10.1542/peds.2003-0264-F
Stringaris, A. (2011). Irritability in children and adolescents: A challenge for DSM-5. European Child & Adolescent Psychiatry, 20(2), 61-66. DOI: https://doi.org/10.1007/s00787-010-0150-4
Stringaris, A., Baroni, A., Haimm, C., Brotman, M., Lowe, C. H., Myers, F., Rustgi, E., Wheeler, W., Kayser, R., Towbin, K., & Leibenluft, E. (2010). Pediatric bipolar disorder versus severe mood dysregulation: Risk for manic episodes on fol-low-up. Journal of the American Academy of Child & Adolescent Psychiatry, 49(4), 397-405. DOI: https://doi.org/10.1097/00004583-201004000-00014
Stringaris, A., Cohen, P., Pine, D. S., & Leibenluft, E. (2009). Adult outcomes of youth irritability: A 20-year prospective community-based study. American Journal of Psychiatry, 166(9), 1048-1054. DOI: https://doi.org/10.1176/appi.ajp.2009.08121849
Tourian, L., LeBoeuf, A., Breton, J. J., Cohen, D., Gignac, M., Labelle, R., Guile, J. M., & Renaud, J. (2015). Treatment options for the cardinal symp-toms of disruptive mood dysregulation disor-der. Journal of the Canadian Academy of Child and Adolescent Psychia-try, 24(1), 41.
Towbin, K., Vidal-Ribas, P., Brotman, M. A., Pick-les, A., Miller, K. V., Kaiser, A., Vitale, A. D., En-gel, C., Overman, G. P., Davis, M., Lee, B., McNeil, C., Wheeler, W., Yokum, C. H., Har-ing, C. T., Rou-le, A., Wambach, C. G., Sharif-Askary, B., Pine, D. S., Leibenluft, E., & Strin-garis, A. (2020). A dou-ble-blind randomized placebo-controlled trial of citalopram adjunc-tive to stimulant medication in youth with chronic severe irritability. Journal of the Ameri-can Academy of Child and Adolescent Psy-chiatry, 59(3), 350–361. https://doi.org/10.1016/j.jaac.2019.05.015 DOI: https://doi.org/10.1016/j.jaac.2019.05.015
Vidal-Ribas, P., Brotman, M. A., Valdivieso, I., Leibenluft, E., & Stringaris, A. (2016). The sta-tus of irritability in psychiatry: A conceptual and quan-titative review. Journal of the Ameri-can Academy of Child & Adolescent Psychia-try, 55(7), 556-570. DOI: https://doi.org/10.1016/j.jaac.2016.04.014
West, A. E., Jacobs, R. H., Westerholm, R., Lee, A., Carbray, J., Heidenreich, J., & Pavuluri, M. N. (2009). Child and family-focused cognitive-behavioral therapy for pediatric bipolar disor-der: Pilot study of group treatment format. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 18(3), 239.
Wilens, T. E., Bukstein, O., Brams, M., Cutler, A. J., Childress, A., Rugino, T., Lyne, A., Grannis, K., & Youcha, S. (2012). A controlled trial of extend-ed-release guanfacine and psychostimu-lants for attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 51(1), 74-85. DOI: https://doi.org/10.1016/j.jaac.2011.10.012
Young, M. E., & Fristad, M. A. (2007). Evidence based treatments for bipolar disorder in children and adolescents. Journal of Contemporary Psy-cho-therapy, 37(3), 157-164. DOI: https://doi.org/10.1007/s10879-007-9050-4
Published
Issue
Section
License
Copyright (c) 2022 China Parenteau, Dr. Hendren
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles published in the Journal of Health and Rehabilitation Sciences are licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license permits use, distribution, reproduction, adaptation, and commercial use in any medium or format, provided the original work is properly cited, the authors are credited, and the source is acknowledged.
How to Cite
Citations
